Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions

Lorena Incorvaia , Daniele Fanale , Giuseppe Badalamenti , Camillo Porta , Daniel Olive (1) , Ida de Luca , Chiara Brando , Mimma Rizzo , Carlo Messina , Mattia Rediti , Antonio Russo , Viviana Bazan , Juan Lucio Iovanna (1)

1 CRCM - Centre de Recherche en Cancérologie de Marseille

Domaines: Immunologie

Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, Camillo Porta, Daniel Olive, et al.. Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions. OncoImmunology, 2020, 9 (1), pp.1832348. ⟨10.1080/2162402X.2020.1832348⟩. ⟨hal-03152735⟩